Back
Novel Carbohydrate-substituted Indazole Derivatives Targeting SGLT1 Enhance the Efficacy of Receptor Tyrosine Kinase Inhibitors in Cancer Therapy
Qi, H.; Sun, Z.
2025-01-17
cancer biology
10.1101/2025.01.13.632856
bioRxiv
Show abstract
Withdrawal StatementThe authors have withdrawn this manuscript because [Because we need to conduct a completely different re-examination of the mechanism behind the article]. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
Matching journals
●Non-profit
◐University press
○Commercial
The top 9 journals account for 50% of the predicted probability mass.
1
PLOS ONE
●
5266 papers in training set
Top 13%
13.5%
Similar papers in this journal
- A Priori Activation of Apoptosis Pathways of Tumor (AAAPT) Technology: Development of Targeted Apoptosis Initiators for Cancer Treatment. 93%
- A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin 92%
- Cost-effectiveness of real-world administration of chemotherapy and add-on Viscum album L. therapy compared to chemotherapy alone in the treatment of stage IV NSCLC patients 92%
2
Frontiers in Pharmacology
○
111 papers in training set
Top 0.2%
8.3%
Similar papers in this journal
- Evaluation of the current therapeutic approaches for COVID-19: a meta-analysis 94%
- Core Outcome Set for Clinical Trials of COVID-19 based on Traditional Chinese and Western Medicine 93%
- Molecular mechanism of action of repurposed drugs and traditional Chinese medicine used for the treatment of patients infected with COVID-19: A systematic scoping review 93%
3
Pharmaceuticals
○
34 papers in training set
Top 0.1%
7.6%
Similar papers in this journal
- Correlating basal gene expression across chemical sensitivity data to screen for novel synergistic interactors of HDAC inhibitors in pancreatic carcinoma 92%
- Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical in silico/in vitro screening methods 91%
- Acquired Drug Resistance Enhances Imidazoquinoline Efflux by P-glycoprotein 91%
4
Biochemical Pharmacology
○
20 papers in training set
Top 0.1%
5.8%
Similar papers in this journal
- Transcriptional activation of cyclin D1 via HER2/HER3 contributes to cell survival and EGFR tyrosine kinase inhibitor resistance in non-small cell lung carcinoma 90%
- Pharmacologic and genetic inhibition of cholesterol esterification reduces tumour burden: a pan-cancer systematic review and meta-analysis of preclinical models 90%
- Discovery of a AhR flavonoid agonist that counter-regulates ACE2 expression in rodent models of inflammation and attenuates ACE2-SARS-CoV2 interaction in vitro 90%
5
Molecular Cancer Therapeutics
●
40 papers in training set
Top 0.2%
4.5%
Similar papers in this journal
- Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers 92%
- Immunotherapy with immunocytokines and PD-1 blockade enhances the anticancer activity of small molecule-drug conjugates targeting carbonic anhydrase IX 92%
- Differential alteration of IL-8 in liver cancer stem cell enrichment in response to PI3K/Akt/mTOR inhibitors and sorafenib 90%
50% of probability mass above
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.